UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 412

Sortiert nach

Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher

Oral oncology, 2020-02, Vol.101, p.104492-104492, Article 104492

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in head and neck cancer: aiming at EXTREME precision

BMC medicine, 2017-06, Vol.15 (1), p.110-11, Article 110

2017

Link zum Volltext

Verfügbarkeit prüfen

Management of locally recurrent nasopharyngeal carcinoma

Cancer treatment reviews, 2019-09, Vol.79, p.101890-101890, Article 101890

2019

Link zum Volltext

Verfügbarkeit prüfen

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies

Cancer, 2008-06, Vol.112 (12), p.2710-2719

2008

Link zum Volltext

Verfügbarkeit prüfen

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1056-1066

2017

Link zum Volltext

Verfügbarkeit prüfen

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2854-2860

2013

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Head and neck cancer in the elderly

Frontiers in oncology, 2023-06, Vol.13, p.1218274-1218274

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Insights in head and neck cancer: 2021

Frontiers in oncology, 2023-03, Vol.13, p.1180965-1180965

2023

Link zum Volltext

Verfügbarkeit prüfen

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

The New England journal of medicine, 2008-09, Vol.359 (11), p.1116-1127

2008

Link zum Volltext

Verfügbarkeit prüfen

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2171-2177

2007

Link zum Volltext

Verfügbarkeit prüfen

Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond

Cancers, 2021-05, Vol.13 (11), p.2518

2021

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

The New England journal of medicine, 2007-10, Vol.357 (17), p.1695-1704

2007

Link zum Volltext

Verfügbarkeit prüfen

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

The oncologist (Dayton, Ohio), 2010-07, Vol.15 (7), p.699-731

2010

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

Frontiers in oncology, 2019-06, Vol.9, p.464-464

2019

Link zum Volltext

Verfügbarkeit prüfen

Oligometastatic Disease Management: Finding the Sweet Spot

Frontiers in oncology, 2020-12, Vol.10, p.617793

2020

Link zum Volltext

Verfügbarkeit prüfen

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review

Head & neck, 2016-04, Vol.38 (S1), p.E2151-E2158

2016

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Frontiers in oncology, 2019-02, Vol.9, p.86-86

2019

Link zum Volltext

Verfügbarkeit prüfen

Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice

Current opinion in otolaryngology & head and neck surgery, 2019-04, Vol.27 (2), p.142

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

BMC immunology, 2010-04, Vol.11 (1), p.19-19

2010

Link zum Volltext

Verfügbarkeit prüfen

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3107-3114

2010

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Prevalence of a True Oligometastatic Disease

Cancers, 2022-12, Vol.15 (1), p.214

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti‐Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.850-864

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 412

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Englisch
(411)
Japanisch
(54)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(306)
Science & Technology
(306)
Oncology
(263)
Humans
(220)
Female
(115)
Medical Sciences
(94)
Biological And Medical Sciences
(93)
Middle Aged
(84)
Chemotherapy
(83)
Aged
(73)
Adult
(66)
Pharmacology. Drug Treatments
(64)
Male
(56)
Antineoplastic Agents
(55)
Tumors
(54)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(52)
Head And Neck Cancer
(51)
Head And Neck Neoplasms - Drug Therapy
(47)
Treatment Outcome
(42)
Surgery
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher

Immunotherapy in head and neck cancer: aiming at EXTREME precision

Management of locally recurrent nasopharyngeal carcinoma

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Editorial: Head and neck cancer in the elderly

Editorial: Insights in head and neck cancer: 2021

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

Oligometastatic Disease Management: Finding the Sweet Spot

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Estimating the Prevalence of a True Oligometastatic Disease

Anti‐Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

Suchergebnisse filtern